This inventor holds 1 USPTO granted patent. Top assignee: Targacept, Inc.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Tommi Ratilainen: Innovator in Aryl Substituted Olefinic Amines
Introduction
Tommi Ratilainen is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of chemistry, particularly in the preparation of aryl substituted olefinic amines. His innovative work has led to the development of a patented process that enhances the efficiency of producing these important compounds.
Latest Patents
Tommi Ratilainen holds a patent for a process titled "Process for the preparation of aryl substituted olefinic amines." This patent describes an improved method for synthesizing compounds such as (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine and (2S)-(4E)-N-methyl-5-[3-(5-methoxypyridin)yl]-4-penten-2-amine. The patent also introduces new intermediates that are utilized in this innovative process. He has 1 patent to his name.
Career Highlights
Tommi Ratilainen is currently associated with Targacept, Inc., where he continues to advance his research and development efforts. His work at Targacept has positioned him as a key player in the field of medicinal chemistry, focusing on the synthesis of complex organic molecules.
Collaborations
Throughout his career, Tommi has collaborated with esteemed colleagues, including John Genus and Gary Maurice Dull. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Tommi Ratilainen's contributions to the field of chemistry, particularly through his patented process for aryl substituted olefinic amines, highlight his role as an influential inventor. His ongoing work at Targacept, Inc. and collaborations with other professionals further emphasize his commitment to advancing scientific knowledge and innovation.